Skip to main content
Sign In
 

Natalie Nokoff, MD


Transgender individuals are people whose gender identity does not match their birth sex and are a growing and understudied population. Transgender youth in early puberty may be prescribed a “puberty blocker” that shuts down their body’s production of sex hormones and prevents unwanted secondary sex characteristics from developing. Then, later in adolescence, hormones such as testosterone are often prescribed as a part of their transition to give individuals the secondary sex characteristics that align with their gender identity. Dr. Nokoff is studying the effects of pubertal blockade and testosterone therapy in female-to-male transgender adolescents on insulin sensitivity and vascular health. ​